+Susen Rogen

Monday, 12 August 2013

MediPoint: In-vitro Colorectal Cancer Screening Tests – Global Analysis and Market Forecasts:Life Sciences Market Research Reports

Life Sciences Market Research Reports
 
MediPoint: In-vitro Colorectal Cancer Screening Tests – Global Analysis and Market Forecasts
Aug 9th 2013, 00:00, by rnrmahesh

Colorectal cancer (CRC) is the third most commonly diagnosed cancer, and the second most common cause of mortality amongst cancer patients. Prognosis is directly related to early diagnosis, with survival rates dramatically improved by early diagnosis and treatment. Thanks to the introduction of CRC screening programs, mortality in the developed countries is falling; however incidence continues to rise as a result of diet and increasingly sedentary lifestyles. While historically, colorectal cancer incidence in the developing world is low, in recent years, disease diagnosis rates have dramatically increased, as a result of changing lifestyles, awareness and improved access to medical services. …

Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=110513.

Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/medipoint-in-vitro-colorectal-cancer-screening-tests-global-analysis-and-market-forecasts-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment